Project Name：Fingolimod hydrochloride 

Registration Classification：3.1

Formulations and specifications ：Tablets: 500mg 

Indications：Multiple sclerosis, used for the treatment of relapsing - remitting multiple sclerosis (multiplesclerosis, MS) of new immunosuppressants .

Original Research Company：Novartis Pharma AG 

Progress ：Pharmaceutical Research in progress